High CTSL2 expression predicts poor prognosis in patients with lung adenocarcinoma
Figure 2. CTSL2 expression of patients with lung adenocarcinoma grouped by (A) age, (B) gender, (C) stage, (D) vital status, (E) T classification, (F) N classification, (G) M classification, and (H) residual tumor.